Mechanism
KRAS G12D presented on HLA-A*11:01 or HLA-A*11:02
Assets acting on this target.
- Class
- HLA-restricted KRAS G12D-targeting agent
- Notes
- audit finding #1729 (minor); source: https://clinicaltrials.gov/api/v2/studies/NCT06218914
Mechanism
Assets acting on this target.
1 of 1 assets